These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21810994)
1. The invisible disease: making sense of an osteoporosis diagnosis in older age. Weston JM; Norris EV; Clark EM Qual Health Res; 2011 Dec; 21(12):1692-704. PubMed ID: 21810994 [TBL] [Abstract][Full Text] [Related]
2. Women's experiences of their osteoporosis diagnosis at the time of diagnosis and 6 months later: a phenomenological hermeneutic study. Hansen C; Konradsen H; Abrahamsen B; Pedersen BD Int J Qual Stud Health Well-being; 2014; 9():22438. PubMed ID: 24559545 [TBL] [Abstract][Full Text] [Related]
3. When do bisphosphonates make the most sense? Winzenberg T; Jones G J Fam Pract; 2011 Jan; 60(1):18-28. PubMed ID: 21209974 [No Abstract] [Full Text] [Related]
4. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis. Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732 [TBL] [Abstract][Full Text] [Related]
5. Toward optimal health: advances in diagnosis and preventive strategies to promote bone health in women. Godfrey JR; Rosen CJ J Womens Health (Larchmt); 2008 Nov; 17(9):1425-30. PubMed ID: 18945208 [No Abstract] [Full Text] [Related]
10. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates. Cole RE Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901 [TBL] [Abstract][Full Text] [Related]
11. Screening for osteoporosis. Croswell J Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255 [No Abstract] [Full Text] [Related]
12. Recognition of women at risk for fracture and intervention with fast-acting therapies. Derman R Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104 [TBL] [Abstract][Full Text] [Related]
13. Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva. Robb-Nicholson C Harv Womens Health Watch; 2011 Nov; 19(3):8. PubMed ID: 22276325 [No Abstract] [Full Text] [Related]
14. Bisphosphonates for osteoporosis. Vis M; Dijkmans BA; Lems WF N Engl J Med; 2011 Feb; 364(6):582-3; author reply 583-4. PubMed ID: 21306267 [No Abstract] [Full Text] [Related]
15. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis. Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062 [TBL] [Abstract][Full Text] [Related]
16. Osteoporosis screening and treatment guidelines: are they being followed? Schnatz PF; Marakovits KA; Dubois M; O'Sullivan DM Menopause; 2011 Oct; 18(10):1072-8. PubMed ID: 21753740 [TBL] [Abstract][Full Text] [Related]
17. Screening for osteoporosis: recommendation statement. U.S. Preventive Services Task Force Am Fam Physician; 2011 May; 83(10):1197-200. PubMed ID: 21568254 [No Abstract] [Full Text] [Related]
18. [Treatment of postmenopausal osteoporosis in the general medical practice (clinical case)]. Zhdan VM; Kitura OIe; Kitura IeM; Babanina MIu; Tkachenko MV Lik Sprava; 2013 Mar; (2):85-9. PubMed ID: 24605616 [TBL] [Abstract][Full Text] [Related]
19. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations. Watts NB; Bilezikian JP; Camacho PM; Greenspan SL; Harris ST; Hodgson SF; Kleerekoper M; Luckey MM; McClung MR; Pollack RP; Petak SM Endocr Pract; 2010; 16(6):1016-9. PubMed ID: 21216723 [No Abstract] [Full Text] [Related]